Sight Sciences Inc SGHT
📋 Company Profile
| Industry | Health Care |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2021-07-15 |
| Shares Out. | 54,410,000 |
| Website | sightsciences.com/ ↗ |
| Phone | 14158890550 |
| Employees | 186 |
| Revenue | $19.7M |
| Gross Profit | $17.0M |
| Net Income | -$13.0M |
| Free Cash Flow | -$25.4M |
| Total Assets | $109.7M |
| Total Liabilities | $55.8M |
| Equity | $53.9M |
About Sight Sciences Inc
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The company operates through two segments: Interventional Glaucoma, which generates the majority of revenue and includes the OMNI Surgical System family of products and the SION Surgical Instrument used in minimally invasive glaucoma surgery to reduce intraocular pressure in adult patients with open-angle glaucoma; and Interventional Dry Eye, which includes the TearCare System, an interventional device designed to melt and facilitate the removal of meibomian gland obstructions and restore gland functionality in adult patients with evaporative dry eye disease.
Sight Sciences Inc is a publicly traded company under the ticker symbol SGHT on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
14 analysts (2026-07-01)